Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atricure (ATRC)
NASDAQ:ATRC
Holding ATRC?
Track your performance easily
Earnings Data
Report Date
Feb 25, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.21Last Year’s EPS
-$0.21Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 29, 2024
|% Change Since: 2.11%
|Next Earnings Date:Feb 25, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance for AtriCure with significant revenue growth and positive cash flow. However, there are challenges in maintaining gross margins and increasing operating expenses. While the company is seeing pressure in certain areas due to market dynamics, the overall outlook remains positive with continued investments in innovation and market expansion.Company Guidance
In the third quarter of 2024, AtriCure reported robust financial performance, achieving total revenue of $116 million, reflecting an 18% growth year-over-year. The company successfully raised its full-year 2024 revenue guidance to $459 million to $462 million, representing a 15% to 16% increase over 2023. AtriCure also maintained strong profitability metrics, with nearly $8 million in adjusted EBITDA and over $16 million in positive cash flow for the quarter. Notably, their pain management franchise experienced a 36% worldwide sales growth, fueled by the successful U.S. launch of the cryoSPHERE+ Probe, which contributed significantly to sales. Additionally, their open ablation franchise grew by 16% globally, supported by a 50% growth in EnCompass Clamp sales in the U.S. Furthermore, the appendage management franchise saw an 18% revenue increase worldwide, with notable contributions from open chest devices. The company is also advancing its technological capabilities by entering a partnership to develop PFA technology, aiming to enhance its cardiac surgery devices. Overall, AtriCure's diversified product offerings and strategic innovations continue to drive its strong financial performance and market presence.Strong Revenue Growth
Achieved total revenue of $116 million, approximately 18% growth. Full-year 2024 revenue guidance raised to $459 million to $462 million, reflecting growth of 15% to 16% over 2023.
Profitability and Cash Flow
Produced nearly $8 million of positive adjusted EBITDA for the quarter and generated over $16 million in positive cash flow, marking the second consecutive quarter of positive cash flow.
Pain Management Franchise Growth
Pain management franchise grew 36% worldwide, driven by the U.S. launch of the cryoSPHERE+ Probe, which contributed nearly half of the pain management sales.
Open Ablation and Appendage Management Growth
Open ablation franchise grew 16% worldwide. Appendage management franchise achieved revenue growth of 18% worldwide, with a strong 20% growth in the U.S.
International Market Performance
International revenue reached $20.5 million, up 23.3% on a reported basis, with European sales growing by 33%.
---
ATRC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ATRC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2024 | $29.43 | $34.83 | +18.35% |
| Jul 30, 2024 | $22.00 | $21.57 | -1.95% |
| May 01, 2024 | $24.76 | $22.22 | -10.26% |
| Feb 15, 2024 | $34.21 | $32.72 | -4.36% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Atricure (ATRC) report earnings?
Atricure (ATRC) is schdueled to report earning on Feb 25, 2025, TBA Not Confirmed.
What is Atricure (ATRC) earnings time?
Atricure (ATRC) earnings time is at Feb 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ATRC EPS forecast?
ATRC EPS forecast for the fiscal quarter 2024 (Q4) is -$0.21.
---